Urine Protein:Creatinine Ratio (PCR)
Подробное руководство скоро
Мы работаем над подробным учебным руководством для Urine Protein:Creatinine Ratio. Вернитесь позже для пошаговых объяснений, формул, реальных примеров и экспертных советов.
The Urine Protein:Creatinine Ratio (PCR) is a spot urine test that estimates the degree of proteinuria without the inconvenience of a timed 24-hour urine collection. It exploits the fact that urinary creatinine excretion is relatively constant throughout the day (reflecting steady muscle catabolism), so the ratio of protein to creatinine in a single urine sample approximates the rate of protein excretion over 24 hours. Proteinuria is not merely a marker of kidney disease — it is an independent risk factor for CKD progression, cardiovascular events, and all-cause mortality. The detection and quantification of proteinuria is therefore central to both the diagnosis and risk stratification of CKD under KDIGO guidelines, which incorporate albuminuria (or proteinuria) categories alongside GFR stages. PCR measures total urine protein, including albumin and non-albumin proteins such as immunoglobulin light chains and tubular proteins. This distinguishes it from the Albumin:Creatinine Ratio (ACR), which is more sensitive for early diabetic nephropathy and hypertensive kidney disease. PCR is particularly useful when non-albumin proteinuria is suspected (e.g., myeloma, tubular disorders) or when a combined protein measurement is clinically appropriate. In clinical practice, PCR is used to diagnose nephrotic range proteinuria, monitor response to treatment with ACE inhibitors or angiotensin receptor blockers, guide decisions about immunosuppression in glomerular disease, and assess transplant kidney function. A first-morning void sample is preferred as it avoids the dilutional effect of exercise and postural changes (orthostatic proteinuria).
PCR (mg/mmol) = Urine protein (mg/L) / Urine creatinine (mmol/L) | PCR (mg/g) = [Urine protein (mg/dL) / Urine creatinine (g/dL)] × 10
- 1Collect a spot urine sample — ideally first-morning void to avoid orthostatic proteinuria and exercise-induced transient proteinuria.
- 2Measure urine protein concentration (mg/L or mg/dL) using dipstick, turbidimetric, or colorimetric assay; albumin-specific assays give ACR rather than PCR.
- 3Measure urine creatinine concentration in the same sample (mmol/L in SI units, or g/dL in US conventional units).
- 4Divide urine protein by urine creatinine: PCR (mg/mmol) = protein (mg/L) / creatinine (mmol/L); or PCR (mg/g) = [protein (mg/dL) / creatinine (g/dL)] × 10.
- 5To convert between units: PCR (mg/mmol) × 8.84 ≈ PCR (mg/g); PCR (mg/g) ÷ 8.84 ≈ PCR (mg/mmol).
- 6Correlate with clinical context: PCR >300 mg/mmol (>3,500 mg/g) is nephrotic range; PCR >100 mg/mmol warrants urgent nephrology referral.
- 7Repeat testing on at least two further occasions to confirm persistent proteinuria before attributing to CKD — transient proteinuria occurs with fever, heavy exercise, and urinary tract infection.
This level corresponds to approximately 1.9 g/day. Optimise blood pressure and start RAAS blockade.
150 / 10 = 15 mg/mmol. Just at the KDIGO threshold for significant proteinuria.
Nephrotic range defined as >300 mg/mmol (≈3.5 g/day). Urgent referral and renal biopsy likely needed.
4,500 / 9 = 500 mg/mmol. Far exceeds the nephrotic threshold of 300 mg/mmol.
Heavy proteinuria. Corresponds to approximately 8-10 g/day protein excretion.
(80 / 0.8) × 10 = 1,000 mg/g. Converting: 1,000 / 8.84 ≈ 113 mg/mmol.
Improvement from previous PCR of 120 mg/mmol following immunosuppression. Target is PCR <50 mg/mmol.
300 / 15 = 20 mg/mmol. Significant reduction indicating treatment response.
Quantifying proteinuria in CKD to classify severity (KDIGO A1/A2/A3 categories) and guide treatment intensity., representing an important application area for the Urine Protein Creatinine in professional and analytical contexts where accurate urine protein creatinine calculations directly support informed decision-making, strategic planning, and performance optimization
Monitoring response to RAAS inhibitors (ACE inhibitors, ARBs, ARNIs) or SGLT2 inhibitors in diabetic and non-diabetic CKD., representing an important application area for the Urine Protein Creatinine in professional and analytical contexts where accurate urine protein creatinine calculations directly support informed decision-making, strategic planning, and performance optimization
Detecting relapse or remission of nephrotic syndrome in minimal change disease, FSGS, and membranous nephropathy., representing an important application area for the Urine Protein Creatinine in professional and analytical contexts where accurate urine protein creatinine calculations directly support informed decision-making, strategic planning, and performance optimization
Evaluating proteinuria in transplant recipients to detect rejection, calcineurin inhibitor nephrotoxicity, or recurrent disease., representing an important application area for the Urine Protein Creatinine in professional and analytical contexts where accurate urine protein creatinine calculations directly support informed decision-making, strategic planning, and performance optimization
Screening for significant proteinuria in primary care without the need for 24-hour urine collections., representing an important application area for the Urine Protein Creatinine in professional and analytical contexts where accurate urine protein creatinine calculations directly support informed decision-making, strategic planning, and performance optimization
Orthostatic proteinuria
{'title': 'Orthostatic proteinuria', 'body': 'Common in adolescents and young adults, orthostatic proteinuria disappears in recumbency and has an excellent prognosis. Diagnose by comparing first-morning (lying) and afternoon (standing) PCR. If the morning sample is normal (<15 mg/mmol) and the afternoon sample is elevated, the diagnosis is orthostatic proteinuria — no specific treatment required, but annual review is reasonable.'}
Bence-Jones proteinuria (myeloma)
{'title': 'Bence-Jones proteinuria (myeloma)', 'body': 'Immunoglobulin light chains (Bence-Jones protein) are not detected by standard protein dipstick and may be underrepresented in PCR depending on the assay used. When myeloma is suspected, request serum and urine protein electrophoresis (SPEP/UPEP) and free light chain assay specifically — do not rely on PCR alone.'}
Post-exercise and febrile proteinuria
{'title': 'Post-exercise and febrile proteinuria', 'body': 'Vigorous exercise can cause transient proteinuria up to 300-500 mg/mmol lasting 24-48 hours. Similarly, fever, acute illness, and heart failure can transiently elevate PCR. Always confirm persistent proteinuria on at least two samples taken at rest, at least 1-3 months apart, before diagnosing CKD proteinuria.'}
Low creatinine excretion (sarcopenia)
In the Urine Protein Creatinine, this scenario requires additional caution when interpreting urine protein creatinine results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when urine protein creatinine calculations fall into non-standard territory.
| Category | PCR (mg/mmol) | PCR (mg/g) | Approx. 24h protein | Clinical significance |
|---|---|---|---|---|
| Normal | < 15 | < 130 | < 0.15 g/day | No proteinuria |
| Mild (A2) | 15–50 | 130–440 | 0.15–0.5 g/day | Significant; monitor and treat BP/RAAS |
| Moderate (A3 low) | 50–100 | 440–880 | 0.5–1 g/day | Significant CKD risk; nephrology review |
| Heavy (A3 high) | 100–300 | 880–2,650 | 1–3 g/day | Urgent nephrology referral |
| Nephrotic range | > 300 | > 2,650 | > 3.5 g/day | Urgent assessment; biopsy likely |
What is the difference between PCR and ACR?
PCR measures total urine protein (albumin plus non-albumin proteins), while ACR (Albumin:Creatinine Ratio) measures only albumin. ACR is more sensitive for early diabetic nephropathy and hypertensive kidney disease. PCR is preferred when non-albumin proteinuria is suspected (e.g., myeloma kidney, tubular disorders). For CKD staging, KDIGO now recommends ACR as the primary measure, but PCR is widely used in practice.
Why is a first-morning urine sample preferred?
Urine protein excretion increases during the day with activity and upright posture (orthostatic proteinuria), which is a benign condition in young adults. First-morning urine reflects overnight recumbent production, giving the most reproducible estimate of pathological proteinuria. Exercise within 24 hours can also cause transient proteinuria unrelated to kidney disease. This is particularly important in the context of urine protein creatinine calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise urine protein creatinine computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
How do I convert PCR mg/mmol to mg/g?
Multiply mg/mmol by 8.84 to get mg/g (because 1 mmol creatinine = 113 mg, and 1,000 mg/113 = 8.84). For example, PCR 30 mg/mmol = 30 × 8.84 = 265 mg/g. Going the other way, divide mg/g by 8.84. This is particularly important in the context of urine protein creatinine calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise urine protein creatinine computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
What PCR level requires urgent nephrology referral?
NICE guidelines (UK) recommend urgent referral to nephrology if PCR exceeds 100 mg/mmol (approximately 1 g/day), particularly if associated with haematuria, deteriorating GFR, or hypertension. PCR >300 mg/mmol (nephrotic range) always warrants urgent specialist assessment and likely renal biopsy. This is particularly important in the context of urine protein creatinine calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise urine protein creatinine computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
Can PCR be falsely elevated or low?
Yes. Falsely elevated PCR occurs with highly concentrated urine (low fluid intake), urinary tract infection (where bacteria and white cells contribute protein), myoglobinuria (muscle breakdown), and recent heavy exercise. Falsely low PCR may occur in very dilute urine, high muscle mass patients who excrete more creatinine, or in conditions causing very low creatinine excretion (e.g., cachexia).
Is PCR equivalent to a 24-hour urine protein?
PCR is a validated approximation. PCR (mg/mmol) correlates numerically with 24-hour protein excretion in grams per day (e.g., PCR 100 mg/mmol ≈ 1 g/day; PCR 300 mg/mmol ≈ 3 g/day). However, the correlation is imperfect — patients with irregular creatinine excretion (extreme muscle mass, fluctuating diet) may show discordance. A timed 24-hour collection remains the reference standard when precision is critical.
What causes proteinuria in CKD?
In glomerular disease (diabetic nephropathy, IgA nephropathy, minimal change, focal segmental glomerulosclerosis), the glomerular filtration barrier is damaged, allowing albumin and larger proteins to pass. In tubular disease, filtered proteins are not adequately reabsorbed. Overflow proteinuria occurs when plasma proteins are produced in excess (e.g., immunoglobulin light chains in myeloma), overwhelming tubular reabsorption.
Does proteinuria treatment actually improve outcomes?
Yes. Reducing proteinuria with ACE inhibitors, angiotensin receptor blockers, or SGLT2 inhibitors slows CKD progression and reduces cardiovascular risk. Target PCR is typically <50 mg/mmol (some guidelines <30 mg/mmol). The SPRINT, RENAAL, and DAPA-CKD trials demonstrated that reducing proteinuria via blood pressure and RAAS control significantly reduces endpoints including dialysis and death.
Совет профессионала
A PCR result in mg/mmol is numerically similar to 24-hour protein in g/day when multiplied by roughly 0.1. So PCR 50 mg/mmol ≈ 0.5 g/day, and PCR 300 mg/mmol ≈ 3 g/day. This rough mental model helps interpret results quickly at the bedside, though formal correlation is stronger in non-sarcopenic patients.
Знаете ли вы?
The idea of using the protein:creatinine ratio was first proposed in the 1980s when nephrologists noticed that creatinine excretion is remarkably constant from day to day in stable patients — roughly 1 gram per day per 20 kg of lean body mass. By using this biological 'internal standard', a two-minute spot test replaced the cumbersome process of collecting all urine produced over an entire day.
Источники
- ›KDIGO 2024 CKD Guidelines — Proteinuria Assessment
- ›Ruggenenti P et al. (1998) — Urinary protein excretion rate is the best independent predictor of ESRD in non-diabetic proteinuric CKD. Kidney Int.
- ›NICE Guideline NG203 — Chronic Kidney Disease (2021)
- ›Price CP et al. (2005) — Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria. BMJ.
- ›Heerspink HJL et al. (2020) — Dapagliflozin in patients with CKD (DAPA-CKD). NEJM.